Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
98 hedge funds and large institutions have $176M invested in Aratana Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 28 reducing their positions, and 19 closing their positions.
325% more call options, than puts
Call options by funds: $17K | Put options by funds: $4K
39% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 28
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 103 → 98 (-5)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
37% less capital invested
Capital invested by funds: $279M → $176M (-$103M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$14M |
| 2 |
Millennium Management
New York
|
+$5.01M |
| 3 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$2.91M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$2.79M |
| 5 |
Renaissance Technologies
New York
|
+$2.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.5M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$6.07M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.86M |
| 4 |
CCI
Columbus Circle Investors
|
-$5.8M |
| 5 |
State Street
Boston,
Massachusetts
|
-$4.27M |
PETX Hedge Fund Activity: Q4 2015 in Review
98 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q4 2015, worth a combined $176M — down 37% from $279M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of PETX and 15 opened new positions — a net loss of 4 holders — while 28 trimmed existing stakes and 39 added.
The largest buyer was Broadfin Capital, adding an estimated $14M. The largest seller was Wellington Management Group, cutting an estimated $12.5M.
- 98 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q4 2015, down from 103 in Q3 2015.
- Funds reported $176M of Aratana Therapeutics, Inc. stock for Q4 2015, down 37% quarter-over-quarter.
- 15 funds opened new Aratana Therapeutics, Inc. positions in Q4 2015 and 19 closed out, a net change of -4 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q4 2015 was Broadfin Capital, an estimated $14M added.
- The largest Aratana Therapeutics, Inc. seller in Q4 2015 was Wellington Management Group, an estimated $12.5M sold.
Based on aggregated 13F filings for Q4 2015.